BAYZED HEALTH (02609): Adoption of the 2026 Stock Incentive Plan.

date
21:00 23/06/2026
avatar
GMT Eight
Bai Ze Medical (02609) announced that the company has adopted the plan on June 23, 2026. The plan will be implemented using existing shares only, without any issuance of new shares. The plan will be valid for ten years from the adoption date, with a maximum limit of 20 million shares that can be awarded. The trustee will purchase shares from the secondary market as directed by the board of directors, in accordance with the plan rules and trust deed, to fulfill the exercise of awards.
BAYZED HEALTH (02609) announced that the company has adopted the plan on June 23, 2026. The plan will only be paid with existing shares and does not involve the issuance of any new shares. The plan will be valid for ten years from the adoption date, with a maximum limit of 20 million shares that can be granted under the plan. The trustee will purchase shares from the secondary market according to the instructions of the board of directors, in accordance with the plan rules and trust deed to fulfill the exercise of rewards. The purpose of the plan is to (i) recognize the contributions of eligible participants and provide additional incentives to achieve performance goals, in order to achieve the goal of increasing the company's value; and (ii) attract suitable personnel to promote further development of the group.